Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and surface components encompass the structural barriers and functional interfaces of bacteria, fungi, and other microorganisms. In bacteria, the cell envelope typically includes a cytoplasmic membrane and a peptidoglycan-based cell wall, with Gram-negative species possessing an additional outer membrane rich in lipopolysaccharides (LPS) [1: Silhavy et al., 2010, Cold Spring Harb Perspect Biol]. Fungal cells are distinguished by a cell wall containing chitin and beta-glucans, and a plasma membrane where ergosterol replaces cholesterol as the primary sterol [2: Gow et al., 2017, Microbiol Spectr]. These structures are vital for maintaining osmotic pressure, regulating nutrient transport, and facilitating host-pathogen interactions [3: Strahl & Hamoen, 2010, PNAS]. Because many of these components are absent in mammalian cells, they serve as primary targets for antimicrobial therapy to achieve selective toxicity. For instance, beta-lactam antibiotics inhibit the cross-linking of peptidoglycan, while polymyxins act as detergents to disrupt the outer membrane of Gram-negative bacteria [4: Brown & Wright, 2016, Nature]. Antifungal agents like polyenes and echinocandins target ergosterol and glucan synthesis, respectively, to compromise fungal integrity [5: Nett & Andes, 2016, Infect Dis Clin North Am].
Inhibition of peptidoglycan synthesis, disruption of cytoplasmic membrane potential, binding to ergosterol to form membrane pores, and inhibition of beta-glucan synthesis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and surface components.